CCM
TECH icon

Coldstream Capital Management’s Bio-Techne TECH Stock Holding History

Coldstream Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
36,070
+28,681
+388% +$1.55M 0.03% 252
2026
Q1 		$386K Buy
7,389
+300
+4% +$18K ﹤0.01% 835
2025
Q4 		$417K Buy
7,089
+1,249
+21% +$75.9K 0.01% 781
2025
Q3 		$325K Buy
5,840
+621
+12% +$33.3K ﹤0.01% 902
2025
Q2 		$269K Buy
5,219
+119
+2% +$5.98K ﹤0.01% 939
2025
Q1 		$299K Sell
5,100
-231
-4% -$15.7K 0.01% 808
2024
Q4 		$384K Buy
5,331
+523
+11% +$38.4K 0.01% 711
2024
Q3 		$384K Buy
4,808
+336
+8% +$25.2K 0.01% 715
2024
Q2 		$320K Buy
4,472
+203
+5% +$14.9K 0.01% 734
2024
Q1 		$301K Sell
4,269
-155
-4% -$11.1K 0.01% 770
2023
Q4 		$341K Buy
4,424
+665
+18% +$43.8K 0.01% 656
2023
Q3 		$256K Sell
3,759
-375
-9% -$29.6K 0.01% 656
2023
Q2 		$337K Sell
4,134
-345
-8% -$27.7K 0.01% 582
2023
Q1 		$332K Sell
4,479
-560
-11% -$43.2K 0.01% 589
2022
Q4 		$418K Buy
+5,039
New +$400K 0.02% 490
2022
Q2 		$416K Buy
4,796
+144
+3% +$13.5K 0.02% 457
2022
Q1 		$503K Buy
4,652
+220
+5% +$22.7K 0.02% 379
2021
Q4 		$573K Buy
+4,432
New +$543K 0.02% 373
2017
Q1 		– Sell
-18,632
Closed -$479K – 264
2016
Q4 		$479K Buy
18,632
+6,632
+55% +$174K 0.08% 157
2016
Q3 		$328K Sell
12,000
-16,696
-58% -$459K 0.06% 167
2016
Q2 		$809K Buy
28,696
+17,908
+166% +$460K 0.14% 111
2016
Q1 		$255K Sell
10,788
-316
-3% -$6.96K 0.05% 200
2015
Q4 		$250K Buy
+11,104
New +$253K 0.05% 151

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Coldstream Capital Management's TECH Position: Q2 2026 in Review

Coldstream Capital Management increased its Bio-Techne (TECH) stake by 388% in Q2 2026, buying an estimated $1.55M and bringing the position to 36,070 shares worth $2.55M. The position accounts for 0.03% of the portfolio, ranked #252.

Coldstream Capital Management first reported a position in TECH in Q4 2015 and has held it in 23 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Coldstream Capital Management held 36,070 shares of Bio-Techne worth $2.55M as of Q2 2026.
  • Coldstream Capital Management bought 28,681 Bio-Techne shares in Q2 2026, an estimated $1.55M.
  • Bio-Techne made up 0.03% of Coldstream Capital Management's portfolio in Q2 2026, its #252 holding.
  • Coldstream Capital Management first reported a position in Bio-Techne in Q4 2015 and has held it in 23 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.